Cancer inflammation

Malignant Inflammation

Cutaneous T-cell lymphomas (CTCL) are characterized by the presence of skin lesions containing malignant T cells in the background of a chronic inflammatory cell infiltrate. Early disease presents as ...

Read more »

Bacteria fuel cancer

Bacteria fuel cancer

Cutaneous T-cell lymphoma (CTCL) is characterized by proliferation of malignant T cells in a chronic inflammatory environment. With disease progression, bacteria colonize the compromised
skin barrier and ...

Read more »

Professor Niels Ødum

Prof. Niels Ødum

Author of more than 250 papers in peer-reviewed journals and patents/patent applications within the fields of cancer inflammation, immunology, lymphoma, inflammation, immune pathology, signal transduction and gene regulation.

View details »

miRNA illustration

MicroRNA in
inflammation and cancer

Recently, non-coding microRNAs (miRNAs) have been implicated in the pathogenesis of lymphomagenesis as malignant T cells display a decreased expression of miRNA when compared to non-malignant T cells.

Read more »

Cutaneous T cell lymphoma

Cutaneous T cell lymphoma (CTCL)

CTCL is a non-Hodgkin’s lymphoma involving mature skin-resident T lymphocytes. Prognosis is favorable for early-stage patients, with life span approaching that of healthy age-matched controls. However...

Read more »

Generic placeholder image

Courses & Teaching

Our scientific staff teach BSc and MSc courses in immunology, microbiology, tropical medicine, human biology, cell biology, hygiene, infectious diseases, and molecular biology.

Go to ISIM website »

Loading the player...

MRSA interview
with Prof. Niels Feentved Ødum

by Markus Skiöld Østerud, 9.b Ordrup Skole (2015)

Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that causes infections in different parts of the body. It's tougher to treat than most strains of staphylococcus aureus because it's resistant to some commonly used antibiotics.

MRSA infection
When something you trust fails.

MRSA infection is caused by a type of Staphylococcus aureus bacteria that is resistant to antibiotics used to treat most staph infections. Staphylococcus bacteria live normally on the skin and mucous membranes (e.g., nose) in about 30 percent of people. When these bacteria enter the body (e.g., through a cut or break in the skin, or a surgical wound), they can cause staph infection.

The symptoms of MRSA depend on where you're infected. Most often, it causes mild infections on the skin, like sores or boils. But it can also cause more serious skin infections or infect surgical wounds, the bloodstream, the lungs, or the urinary tract.

Though most MRSA infections aren't serious, some can be life-threatening. Many public health experts are alarmed by the spread of tough strains of MRSA. Because it's hard to treat, MRSA is sometimes called a "super bug."

MRSA cells